Track Krishna Institute of Medical Sciences Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Krishna Institute of Medical Sciences Limited KIMS.NS · Stock Open Krishna Institute of Medical Sciences Limited in new tab

668.55 INR
P/E
131.09
EPS
5.10
P/B
11.90
ROE
9.72
Beta
0.27
Target Price
868.00 INR
Loading chart...
Key Metrics
Earnings dateNov. 6, 2026
P/E131.09
EPS5.10
Book Value56.17
Price to Book11.90
Debt/Equity166.23
% Insiders41.736%
Growth
Revenue Growth0.35%
Earnings Growth-0.47%
Estimates
Forward P/E39.43
Forward EPS16.96
Target Mean Price868.00

DCF valuation

Model fair value for Krishna Institute of Medical Sciences Limited (KIMS.NS)
Result
Sign in to run the valuation for KIMS.NS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
16 analysts · consensus Strong buy · mean target 868.00 INR (low 740.00, high 1000.00) · as of 22 Oct 2026
Low 740.00
Mean 868.00
High 1000.00
Price 668.55
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Krishna Institute of Medical Sciences Limited Logo Krishna Institute of Medical Sciences Limited Analysis (KIMS.NS)

Is Krishna Institute of Medical Sciences Limited a good investment? Krishna Institute of Medical Sciences Limited (KIMS.NS) is currently trading at 668.55 INR. Market analysts have a consensus price target of 868.00 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 131.09. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Krishna Institute of Medical Sciences Limited is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is 16.96.

Investor FAQ

Does Krishna Institute of Medical Sciences Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of 5.10.

Company Profile

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics. Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Trades
Dividend History paid per year (INR)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Sept. 13, 2024 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion